Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting.

Saved in:
Bibliographic Details
Title: Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting.
Authors: Miller MS; Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland, USA., Allen PJ; Division of Surgical Oncology, Duke Cancer Institute, Durham, NC, USA., Brown PH; Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, MD Anderson Cancer Center, Houston, TX, USA., Chan AT; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, USA., Clapper ML; Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Dashwood RH; Center for Epigenetics & Disease Prevention, Institute of Biosciences & Technology, Texas A&M Health Science Center, Houston, TX, USA., Demehri S; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA., Disis ML; Cancer Vaccine Institute, University of Washington School of Medicine, Seattle, WA, USA., DuBois RN; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA., Glynn RJ; Division of Preventive Medicine, Brigham & Women's Hospital, Boston, MA, USA., Kensler TW; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Khan SA; Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Johnson BD; Department of Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI, USA., Liby KT; Department of Pharmacology & Toxicology, Michigan State University, East Lansing, Michigan, NY, USA., Lipkin SM; Division of Gastroenterology and Hepatology, Weill Cornell University, New York, NY, USA., Mallery SR; Department of Oral and Maxillofacial Pathology, College of Dentistry, Ohio State University, Columbus, OH, USA., Meuillet EJ; PHusis Therapeutics, San Diego, CA, USA., Roden RBS; Department of Pathology, Cancer Prevention and Control Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Schoen RE; Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Sharp ZD; Department of Molecular Medicine, University of Texas Science Center at San Antonio, San Antonio, TX, USA., Shirwan H; Department of Child Health and Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, USA., Siegfried JM; Department of Pharmacology, Masonic Cancer Center, University of Minnesota School of Medicine, Minneapolis, MN, USA., Rao CV; Medical Oncology Center for Cancer Prevention & Drug Development, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., You M; Department of Pharmacology and Toxicology, Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA., Vilar E; Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, MD Anderson Cancer Center, Houston, TX, USA., Szabo E; Lung and Upper Aerodigestive Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA., Mohammed A; Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland, USA.
Source: Journal of cancer prevention [J Cancer Prev] 2021 Mar 30; Vol. 26 (1), pp. 71-82.
Publication Type: Journal Article
Journal Info: Publisher: Korean Society of Cancer Prevention Country of Publication: Korea (South) NLM ID: 101615965 Publication Model: Print Cited Medium: Print ISSN: 2288-3649 (Print) Linking ISSN: 22883649 NLM ISO Abbreviation: J Cancer Prev Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2288-3649
DOI:10.15430/JCP.2021.26.1.71